Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.51 USD | -.--% | -.--% | -.--% |
Strengths
- This company will be of major interest to investors in search of a high dividend stock.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- Low profitability weakens the company.
Ratings chart - Surperformance
Sector: Specialized REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 1.6B | - | - | |
+4.62% | 55.76B | A- | ||
-11.72% | 17.72B | A- | ||
-5.05% | 13.23B | A | ||
+1.40% | 7.68B | B | ||
-17.93% | 5.39B | B- | ||
+8.62% | 3.28B | C- | ||
-5.42% | 3.06B | B+ | ||
-8.15% | 2.73B | C | ||
+12.61% | 2.73B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- AHR Stock
- GRAH Stock
- Ratings American Healthcare REIT, Inc.